🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“Physical activity can help you manage your bronchiectasis symptoms much better.” Donatella from the ELF Bronchiectasis PAG shared how exercise helps her. #Bronchiectasis2025 🔗 Learn about the benefits of keeping active: europeanlung.org/en/information… EMBARC ERS

What a fantastic day it has been at our #Bronchiectasis2025 Patient Conference! 💙 We heard insights from patients and experts, shared practical advice and answered over 300 questions on #bronchiectasis. Recordings will be available within 2 weeks! europeanlung.org/en/get-involve…

Thank you for all of the speakers and attendees for making this an unforgettable EMBARC/European Lung Foundation patient conference Always a highlight of the year ❤️😀👏🎉

New EMBARC registry data published ThoraxBMJ - study from 31 countries Inhaled corticosteroids are used by 52.3% of bronchiectasis patients Outcomes are generally worse among ICS users which may be confounding by indication Eosinophilic patients have lower exacerbations!

Incredible results for the DPP1 inhibitor HSK31858 from a Ph2 trial in China Great work Prof Zhong, Prof Guan and colleagues 59% reduction in exacerbations at the highest dose. Further evidence that targeting neutrophilic inflammation provides large benefits in bronchiectasis

Just published online at ERS publications ERR A deep dive into neutrophils and their role in bronchiectasis An exciting new era with therapies targeting this treatable trait

Alan Timothy from the European Lung Foundation EMBARC patient advisory group at ESCMID2025 sharing his story with bronchiectasis and pseudomonas infection The only patient speaker at the conference! #patientsinvolved Amazing talk 👏👏

Just out 🔥🔥 Hydrocortisone in severe community acquired pneumonia - results from REMAP-CAP 7 day fixed dose hydrocortisone - Stopped for futility 15% mortality with HC vs 9.8% with standard care. Unlikely that hydrocortisone substantially reduce mortality in CAP.

Thank you ATS Blue Journal for highlighting the brilliant Emma Johnson as an emerging investigator in this months Blue Journal for her groundbreaking work on anti-inflammatory treatments for bronchiectasis #proud #simplythebest

🔥 🔥 🔥 Hot of the press: Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial Article: buff.ly/2HsFkW7 Editorial: buff.ly/fHEPmaY

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial A novel treatment for bronchiectasis Emma Johnson James D Chalmers 🔗 bit.ly/3GQmGkg

🌟🌟🌟🌟

📣 Missed the abstract deadline? Late-Breaking Abstracts (posters only) are now OPEN! 🗓️ Submit by 6 June to join #WBConf25 🎓 Share your work with a global audience! 🔗 world-bronchiectasis-conference.org/2025 #Bronchiectasis #MedTwitter #AbstractCall

Video completo de la 1a Jornada de Actualización en #Bronquiectasias del Hospital Clínic Magníficas charlas sobre diagnóstico, manejo en Atención Primaria, consulta monográfica, Fisioterapia, novedades terapéuticas, rasgos tratables y Atb inhalados 👉youtu.be/WJ48fM9WssM

Delighted to share "Phenotypes and endotypes in bronchiectasis: a narrative review of progress toward precision medicine", coauthored by brilliant Yonghua Gao in a special #bronchiectasis series edited by James D Chalmers and Prof Guan of J Thorac Dis! jtd.amegroups.org/article/view/9…

What a joy to spend a few days with my dear friend and colleague Oriol Sibila plus Lídia Perea Rosa Faner Beatriz Herrero and many others Amazing research into bronchiectasis happening in Barcelona ❤️ EMBARC #collaboration

In particular look out for Merete Long presenting new clinical trial data from the GREAT-2 trial on a monoclonal antibody against Pseudomonas aeruginosa. Presented on Monday Don't miss it! Tayside Clinical Trials Unit AstraZeneca Rebecca Hull University of Dundee Oriol Sibila Stefano Aliberti EMBARC

Save the Date: 8ª edição da World Bronchiectasis Conference (WBC 2025). ➡️ Saiba mais: sbi.org.br/eventos-2/save…

The new EMBARC bronchiectasis website is live Join us for bronchiectasis news, information and take part in a fantastic community bronchiectasis.net/news/ Join us also on Linkedin- linkedin.com/company/embarc… Stefano Aliberti Kara Robertson ERS European Lung Foundation

James D Chalmers Merete Long EMBARC 😍